CAMZYOS

Identification of Camzyos

No description

Google image searchProduct monograph

Active ingredient

mavacamten, 2.5 MG

DIN: 02532549

Dosage form(s): CAPSULE

Route(s) of administration: ORAL

Schedule: Prescription

Company: BRISTOL-MYERS SQUIBB CANADA

Date: 09-JAN-2023

ATC:

• C01 — CARDIAC THERAPY (ATC, ATC/DDD, )
• C01E — OTHER CARDIAC PREPARATIONS (ATC, ATC/DDD)
• C01EB — Other cardiac preparations (ATC, ATC/DDD)
• C01EB24 — MAVACAMTEN (ATC/DDD)

Reference brand drug: Camzyos

External Links for Camzyos

Search on Google

• Camzyos side effects
• Camzyos dosage
• mavacamten side effects
• mavacamten dosage

Bristol-Myers Squibb Canada

Go to Bristol-Myers Squibb website to see drug product details. Sometimes you can find camzyos photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.